These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 25041536)
1. Harmonization of quantitative BCR-ABL measurements using the secondary reference material anchored to the WHO primary standards. Yamada H; Tabe Y; Watanabe K; Morishita S; Yuri M; Yokoo M; Horii T; Shimizu N; Kimura S; Ohsaka A Int J Lab Hematol; 2015 Apr; 37(2):e29-33. PubMed ID: 25041536 [No Abstract] [Full Text] [Related]
2. A novel aberrant form of e13a2 BCR-ABL1 transcript in chronic myelogenous leukemia undetectable with the standardized real-time quantitative polymerase chain reaction from the Europe Against Cancer Program. Matsushita H; Yamamoto M; Tsuboi K; Masukawa A; Arakawa S; Asai S; Ogawa Y; Ando K; Miyachi H Clin Chem Lab Med; 2009; 47(7):885-7. PubMed ID: 19575551 [No Abstract] [Full Text] [Related]
3. Identification of e19a2 BCR-ABL fusions (mu-BCR breakpoints) at the DNA level by ligation-mediated PCR. Boeckx N; Jansen MW; Haskovec C; Vandenberghe P; van der Velden VH; van Dongen JJ Leukemia; 2005 Jul; 19(7):1292-5. PubMed ID: 15843824 [No Abstract] [Full Text] [Related]
5. Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCR. Oehler VG; Qin J; Ramakrishnan R; Facer G; Ananthnarayan S; Cummings C; Deininger M; Shah N; McCormick F; Willis S; Daridon A; Unger M; Radich JP Leukemia; 2009 Feb; 23(2):396-9. PubMed ID: 18615105 [No Abstract] [Full Text] [Related]
6. [Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR]. Yagasaki F; Niwa T; Abe A; Ishikawa M; Kato C; Ogura K; Sasaki H; Kyo T; Jinnai I; Bessyo M; Miyamura K Rinsho Ketsueki; 2009 Jun; 50(6):481-7. PubMed ID: 19571508 [TBL] [Abstract][Full Text] [Related]
7. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients. Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751 [TBL] [Abstract][Full Text] [Related]
8. Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay. Chung HJ; Hur M; Yoon S; Hwang K; Lim HS; Kim H; Moon HW; Yun YM Ann Lab Med; 2020 Jan; 40(1):72-75. PubMed ID: 31432643 [TBL] [Abstract][Full Text] [Related]
9. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis]. Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653 [TBL] [Abstract][Full Text] [Related]
10. Highly sensitive and quantitative detection of BCR-ABL kinase domain mutations by ligation PCR. Pelz-Ackermann O; Cross M; Pfeifer H; Deininger M; Wang SY; Al-Ali HK; Niederwieser D; Lange T Leukemia; 2008 Dec; 22(12):2288-91. PubMed ID: 18615107 [No Abstract] [Full Text] [Related]
12. Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making? Faderl S; Talpaz M; Kantarjian HM; Estrov Z Blood; 1999 May; 93(9):2755-9. PubMed ID: 10216068 [No Abstract] [Full Text] [Related]
13. Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia. Branford S; Cross NC; Hochhaus A; Radich J; Saglio G; Kaeda J; Goldman J; Hughes T Leukemia; 2006 Nov; 20(11):1925-30. PubMed ID: 16990771 [TBL] [Abstract][Full Text] [Related]
14. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624 [TBL] [Abstract][Full Text] [Related]
15. Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. Müller MC; Erben P; Saglio G; Gottardi E; Nyvold CG; Schenk T; Ernst T; Lauber S; Kruth J; Hehlmann R; Hochhaus A; Leukemia; 2008 Jan; 22(1):96-102. PubMed ID: 17943168 [TBL] [Abstract][Full Text] [Related]
16. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers. Furukawa Y; Ju SL; Cho HL; Tatsumi N Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218 [TBL] [Abstract][Full Text] [Related]
17. Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia. Satoh Y; Masuda A; Jona M; Nannya Y; Yokota H; Kurokawa M; Yatomi Y Eur J Haematol; 2014; 92(5):456-7. PubMed ID: 24373003 [No Abstract] [Full Text] [Related]